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INTRODUCTION
 Non-variceal acute lower gastrointestinal 
haemorrhage (NVAGIH) is a life threatening 
abdominal emergency. Anatomically, 
gastrointestinal haemorrhage has been divided 
into upper and lower gastrointestinal bleeding 
by the ligament of Treitz.1 Lower gastrointestinal 
(LGI) haemorrhage has an incidence of 20.5 per 
100,000 patients with a mortality rate of about 
2-5%.2,3 Most cases of gastrointestinal haemorrhage 
are controlled with supportive measures, but, 
a significant number of patients require further 
interventions, which often involve collaborative 
efforts between gastroenterologists, surgeons and 
interventional radiologists. Among the available 
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non variceal acute gastrointestinal hemorrhage
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ABSTRACT
Objectives: To compare the efficacy of polyvinyl alcohol (PVA) particles with microcoils in angiembolisation 
of non variceal acute gastrointestinal haemorrhage.
Methods: This  is  a  retrospective  cross-sectional  study  of  patients  who  underwent  transcatheter 
angioembolization from January, 1995 to December, 2013 at Aga Khan University Hospital, Karachi. Patients 
were divided into two groups on basis of use of either microcoils or PVA particles and compared in terms 
of technical  success, clinical success,  re-bleeding and  ischemic complication rates. Chi  (χ2)  square and 
Fisher’s exact tests were applied and a P-value of less than 0.05 was considered statistically significant.
Results: Fifty seven patients underwent angioembolization. Microcoil and PVA particles embolization was 
performed in 63% (36/57) and 35% (20/57) cases respectively. Technical success was achieved in all cases 
(100%).  Clinical  success  rate was  higher  in microcoils  group  (92%)  than  PVA particles  group  (75%) with 
statistically significant P value (p=0.048). Ischemic complication was seen in one case (3%) in the microcoil 
group, while no such complications were seen in the PVA particles group.
Conclusion: In angioembolization of non variceal acute gastrointestinal haemorrhage microcoils are better 
than Polyvinyl alcohol particles with higher clinical success and lower re-bleed rates.
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particles.
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treatment modalities, endoscopy is the modality 
of first choice.4,5 However, in some emergency 
situations, presence of faecal matter and blood clots 
can obscure the source of the haemorrhage making 
endoscopy inconclusive.6 Surgery offers curative 
and definitive treatment, but, it is associated with 
significant morbidity and mortality ranging from 
10-15%.7 Particularly, in patients with severe co-
morbidities, this mortality rate reaches up to 30%.8
 Catheter angioembolization is becoming a 
popular and viable option for the management 
of patients with NVAGIH. Multiple embolic 
materials are available like detachable fibre coils, 
platinum coils, detachable balloons, particles and 
gel foam.9,10 Among available embolic materials, 
microcoils are easy to use as compared to polyvinyl 
alcohol (PVA) particles. Extensive literature has 
been published on the technical success, clinical 
success and complications rates of catheter 
angioembolization, but, only a few studies have 
compared various embolic agents in terms of their 
individual performance. In this study, we share our 
18-year experience of catheter angioembolization in 
NVAGIH with special focus on efficacy and safety 
of PVA particles vis-á-vis traditional microcoils.
METHODS
 This retrospective study was approved by the 
institutional ethical review board and requirement 
of informed consent was waived. A total of 167 
patients with NVAGIH underwent catheter 
angiography at the radiology department of our 
institution during a period of 18 years (January, 
1995 to December, 2013). Out of these, angiography 
did not reveal any active contrast extravasation in 
106 patients (63%). These patients were managed 
conservatively and subsequently discharged 
from our hospital in stable condition. In 61 
patients (37%), there was active extravasation of 
contrast on angiography and they underwent 
angioembolization using microcoils, PVA particles 
or a combination of these. Three patients from the 
microcoil and one patient from the PVA particles 
group were excluded owing to incomplete medical 
records and/or lost to follow-up. Incomplete 
records was defined as unavailability of daily 
progress notes, physical examination findings 
and/or laboratory results, especially coagulation 
profile, platelet count and haemoglobin level. The 
presence of all of these clinical parameters along 
with complete laboratory results, daily progress 
notes before and after embolization, surgical and 
endoscopy notes (if any) were necessary to label 
a medical record as complete. Radiological data 
was retrieved from our Radiological Information 
System (RIS) and clinical data was obtained from 
the medical records of our hospital. Patients 
included in this study were categorized on the 
basis of the embolization material used into two 
groups i.e. microcoil group (patients treated with 
microcoils only) and PVA particles group (patients 
treated with PVA particles only). Both groups 
were compared in terms of patient demographics, 
presence of co-morbidities, technical success, 
clinical success, re-bleeding and procedure-related 
bowel ischemia. Technical success was defined 
as complete cessation of bleeding achieved at 
the end of the angioembolization procedure as 
demonstrated by final angiogram. Clinical success 
was defined as complete cessation of bleeding 
with angioembolization followed by stability in 
haemodynamics and no re-bleeding within two 
weeks post-procedure. Re-bleeding was assessed 
by pursuing clinical parameters (clearing of aspirate 
from nasogastric tube, no blood per rectum and 
assessment of haematologic and haemodynamic 
parameters). Procedure-related bowel ischemia 
was diagnosed by clinical, endoscopic and surgical 
findings.
Embolization technique: Diagnostic angiography 
was performed in all patients by standard 
transfemoral catheterization technique using a 
5-French vascular access sheath inserted under 
ultrasound and fluoroscopic guidance and a 4-French 
Cobra or Simmon catheter (Cordis, Johnson and 
Johnson, FL, USA) over a 0.035” Terumo Radifocus 
guide wire (Terumo medical corporation, NJ, USA). 
First, selective angiography of celiac, superior 
mesenteric and inferior mesenteric arteries was 
done depending on the findings of endoscopy and/
or red blood cell (RBC)-tagged scintigraphy. Once 
the site of bleeding was identified, superselective 
angiography was performed using a 2.9-French 
microcatheter (Progreat, Terumo, Japan), which was 
inserted co-axially through the already placed 4-Fr 
catheter. Extravasation of contrast media and/or 
the presence of arterial pseudo-aneurysm indicated 
bleeding. Microcatheter was then manipulated to 
reach the vasa recta and angioembolization was 
performed by using either microcoils (size range: 
0.015”-0.018”; Balt, Extrusion, France) [Fig.1] or 
PVA particles (size range: 250-350 μm; Boston 
scientific, Natick, MA, USA) [Fig.2] or both.
Data analysis: Data analysis was performed on SPSS 
software version 14.0. Frequency and percentages 
were computed for categorical variables, while 
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means and standard deviations were calculated for 
continuous variables. Pearson Chi-Square (χ2) and 
Fisher exact tests were used to compare technical 
success, clinical success, re-bleeding and procedure-
related bowel ischemia among both groups. A 
p-value of less than 0.05 was considered statistically 
significant. Multivariate analysis of various factors 
affecting clinical success was also performed.
RESULTS
 A total of 57 patients were included in the final 
analysis. Of these, 63% (36/57) were treated with 
microcoils, 35% (20/57) with PVA particles and 2% 
(1/57) with both materials. In the microcoil group, 
75% (27/36) were male (age range: 21-87 years) and 
25% (9/36) were female (age range: 18-77 years), 
while in the PVA particles group, 70% (14/20) were 
male (age range: 9-75 years) and 30% (6/20) were 
female (age range: 15-64 years). In the microcoil 
group, 50% (18/36) had bleeding per rectum, 47% 
(17/36) had melena and 3% (1/36) presented with 
haematemesis. In the PVA particles group, 70% 
(14/20) patients had bleeding per rectum and 30% 
(6/20) had melena.  Coagulopathy was the most 
common co-morbid condition in both groups. 
Other co-morbidities included uraemia, chronic 
liver disease, hypertension and diabetes mellitus. 
(Table-I)
Comparison of embolics in embolization of GI hemorrhage
Fig.1: Micro coil angioembolisation.
Digital subtraction angiography image showing catheter 
tip in distal branch of left colic artery showing active 
bleed marked by long white arrow. Subsequently 
angioembolisation performed by placement of platinum 
microcoil and complete cessation of bleeding achieved.
Fig.2: Poly vinyl alcohol particle angioembolisation.
a): Digital subtraction angiography image showing 
catheter tip in one of the jejunal branch of superior 
mesenteric artery. b): Subsequent angiogram showed 
active bleeding in one of the distal jejunal branch 
of superior mesenteric artery marked by circle. c): 
Superselective cannulation of bleeding vessel by 
further manipulation of microcatheter. d) Post particle 
embolisation angiogram showing complete cessation of 
bleeding marked by circle (Note: compare with Fig.2.b).
Table-I: Patients Base Line Data. Multivariate analysis.
Comparison of microcoils and PVA particles.
Variables Parameters Microcoils PVA particles P-value (95% CI     Adjusted P-value  
     (36)       (20)     upper, lower ) (95%CI upper, lower)
Gender of patients  Males  27 (75%) 14(70%) 0.332 (.540, 6.202) 0.798 (.2276.879)
 Females  9 (25%) 6 (30%)  
Major comorbids Chronic liver disease  7 (12%) 5 (17%) 0.442(.273,19.460) 0.841 (.10116.815)
 Coagulopathy  24 (41%) 7 (24%) 0.226 (.154, 1.556) 0.483 (.0693,.543)
Major symptoms Bleeding per rectum 18 (50%) 12 (60%) 0.608 (.231, 2.357) 0.862 (.253,3.157)
 Malena 17 (47%) 6 (30%) 0.267 (.154, 1.556) 0.493 (.0693,.543)
Blood transfusion Transfusion done 28(78%) 13 (65%) 0.907(.262, 3.278) 0.665(.240,9.358)
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 In the microcoil group, 78% (28/36) patients 
underwent blood transfusions as compared to 
the PVA particles group, where only 65% (13/20) 
patients underwent blood transfusions. As part 
of initial work-up and treatment, endoscopy 
was performed in 56% (20/36) and 60% (12/20) 
of patients in the microcoil and PVA particles 
groups respectively. In these patients, endoscopic 
methods of haemostasis remained unsuccessful 
and they were subsequently referred for catheter 
angiography and embolization. RBC tagged 
scintigraphy was performed in 39% (14/36) and 
5% (1/20) patients in the microcoil and the PVA 
particles groups respectively. The most common 
site of contrast extravasation was the caecum in 
both groups i.e. 58% (21/36) and 70% (14/20) in the 
microcoil and PVA particles groups respectively. 
The most commonly embolized vessel was the 
ileocolic artery and its branches i.e. 58% (21/36) and 
70% (14/20) in the microcoil and the PVA particles 
groups respectively. Mean follow-up was 19.1 days 
(range: 13-35 days) in the microcoil group, while in 
the PVA particles group, it was 16 days (range: 13-
25 days).
 Technical success was achieved in all patients 
of both groups. Clinical success rate was higher 
with microcoils (33/36 = 92%) than with PVA 
particles (15/20 = 75%) [p=0.048]. Clinical success 
was also achieved in one patient who underwent 
angioembolization with a combination of both 
microcoils and PVA particles. (Table-II) Patients 
undergoing angioembolization with microcoils 
had a re-bleeding rate of 8% (3/36), while it was 
25% (5/20) for patients angioembolized with PVA 
particles (p=0.048).
 Procedure-related bowel ischemia was 
encountered in only one patient undergoing 
microcoil embolization. This particular elderly 
male patient was a known case of diabetes mellitus, 
hypertension and peptic ulcer disease. He had 
recurrent episodes of LGI bleeding in the past, which 
were treated with coil and PVA embolization in the 
region of ascending colon. He also had a previous 
history of laparotomy for repair of ileal perforation. 
This time he had presented with bleeding per rectum. 
On endoscopy, a bleeding focus was found in the 
ascending colon, which was refractory to endoscopic 
treatment and he was subsequently referred for 
angiographic embolization. On angiography, there 
was active extravasation in the territory of the right 
colic artery, which was successfully embolized 
by placing multiple microcoils (size: 0.015”; Balt, 
Extrusion, France). On second post-procedure day, 
he developed abdominal pain along with a fever of 
38oC and tachycardia (pulse rate of 109/min). On 
clinical examination, his abdomen was tense and 
tender. His white cell count was also elevated (12 
x 103 μL). Exploratory laparotomy was performed, 
which revealed an ischemic perforation in the 
ascending colon, for which right hemicolectomy 
was performed. Post-operatively, he remained well 
and was subsequently discharged thereafter.
DISCUSSION
 Superselective transcatheter angioembolization 
has become a safe and effective therapeutic option 
for patients with LGI bleed. This procedure can be 
performed by using temporary as well as permanent 
embolic agents.9,10 Many studies have been 
published regarding the technical success, clinical 
success, re-bleeding rate, procedure-related bowel 
ischemia and mortality rate of angioembolization 
performed with various embolic agents. However, 
most of these were based on a combined analysis 
of various embolic agents. To the best of our 
knowledge, a comparative analysis between various 
embolic agents in terms of their efficacy and safety 
has not been published before. We conducted a 
retrospective comparative analysis in our set of 
patients who underwent angioembolization using 
either microcoils, PVA particles or both.
 In our study, technical success was achieved in 
all cases of LGI bleed with both microcoils and 
PVA particles. This finding is in line with multiple 
studies reported in the literature on GI transcatheter 
embolization.10-25 In studies conducted on LGI bleed 
and achieving 100% technical success, Funaki et 
al.13 and Gillespie et al.23 used microcoils, while 
Guy et al.11 used PVA particles. In the rest of the 
studies,12,14,17 more than one embolic agent was 
employed and comparative analysis was not done. 
Many other studies have reported variable technical 
success rates ranging from 52% to 99%.17-24
 In our study, clinical success ranged from 75% 
(for PVA particles) to 92% (for microcoils) and, 
interestingly, microcoils appeared to have a slightly 
Tanveer-Ul-Haq et al.
Table-II: Angioembolisation performance.
Comparison of microcoils and PVA particles
 Microcoils (36) PVA (20) P value
Technical success 100% (36/36) 100% (20/20)  NA
Clinical success 94% (34/36) 75%   (15/20) 0.048
Rebleed rate 6%  (2/36) 25%   (5/20) 0.048
Bowel Ischemia 3% (1/36) 0%  (0/20) 0.643
Note: Numbers given in parenthesis are patient numbers.
higher clinical success rate than PVA particles. 
Heterogeneity in the granulometric size range 
of PVA particles may result in the formation of 
small aggregates within the microcatheter, thereby 
increasing the theoretic risk of injecting very small 
PVA particles through the microcatheter. However, 
it is also important to note here that the difference 
in the clinical success rates between the two groups 
was only marginal (p=0.048) and this difference 
may be a mere consequence of selection bias due to 
the discrepancy in the number of patients between 
the two groups (n=20 for the PVA particles group 
versus n=36 for the microcoils group). Among the 
studies published in the literature, Gordan et al. 
reported a clinical success rate of 100% by using 
microcoils in eight patients,18 while Waugh et al. 
reported the same for PVA particles in nineteen 
patients.19 Mensel et al. used microcoils for 
embolization of both upper and LGI bleeding in 
acute settings and achieved technical and clinical 
success rates of 88.6% and 56.8% respectively.24 Re-
bleeding in our patients was significantly higher 
with PVA particles (25%) than with microcoils (8%). 
However this difference also remained borderline 
in terms of its statistical significance (p=0.048).  In 
the published literature, re-bleeding rate was 0% 
in the LGI bleed series reported by Gordon et al.18 
and d’Othee et al.15, both of whom used microcoils. 
Similar results were reported by Bandi et al.20, 
though they used more than one embolic agent.
 In our study, there was only one case of 
procedure-related bowel ischemia secondary to 
microcoil embolization of the right colic artery. This 
elderly frail patient with multiple co-morbidities 
had been angioembolized in the past in the same 
vascular territory and a repeat angioembolization 
in the same area blocked all collateral vessels 
resulting in ischemia of the involved segment. In 
multiple studies done on angioembolization for 
LGI haemorrhage, no procedure-related bowel 
ischemia was seen with either microcoils or PVA 
particles.11,12,18,21
Limitations of the study: These must be borne in 
mind before drawing any conclusions. Owing to 
the retrospective study design, sample size was 
not calculated and the number of patients in the 
two groups was not equal. Furthermore, several 
interventional radiologists were involved in the 
angioembolization procedures and this could have 
potentially influenced the clinical success rates 
among the two groups. Patients included in our 
study had a relatively short follow-up period (19.6 
days on average) and some cases of re-bleeding 
might have been missed. Furthermore, due to the 
short follow-up period, long term safety of the 
procedures could not be assessed. 
 Despite the limitations of our study, we have 
provided a retrospective comparative analysis 
between microcoils and PVA particles as embolic 
agents for angioembolization in patients with LGI 
bleeding. The results of our study demonstrate 
the feasibility and safety of both embolic agents 
for angioembolization of patients with NVAGIH. 
Microcoils, being easier to use, can be employed in 
cases where the microcatheter can easily reach the 
vasa recta. However, in technically difficult cases 
where the microcatheter tip cannot be manipulated 
to reach as distal as the vasa recta, PVA particles 
may be a better option. The difference in the clinical 
success and re-bleeding rates noted between 
microcoils and PVA particles in our study is 
intriguing and warrants further validation through 
prospective controlled studies.
CONCLUSION
 In angioembolization of NVAGIH, PVA particles 
are both safe and effective option. However, 
microcoils have higher clinical success and lower 
re-bleeding rates than PVA particles.
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